762 - Motif Bio #MTFB Energiser Investments #ENGI Lombard Risk #LRM plus John Meyer and Alan Green

Apr 20, 2017, 10:59 AM

On the Vox Markets podcast today: 20th April 2017 Graham Lumsden, CEO of Motif Bio #MTFB explains the positive data readout for the Phase 3 Trial of its lead drug, Iclaprim. (Interview starts at 1 minute 51 seconds)

Dominic White, CEO of Energiser Investments #ENGI talks about the completed sale at Kingswood and the Wellingborough portfolio disposal process and also comments on the progress they're making on the acquisition front. (Interview starts at 15 minutes 9 seconds)

James Philips, Group Head of Regulatory Strategy at Lombard Risk Management #LRM off the back of a very positive trading update explains their strengths in the current and future regulatory environment. (Interview starts at 24 minutes 21 seconds)

John Meyer, Mining analyst and partner at SP Angel talks about: Bushveld Minerals #BMN (Interview starts at 31 minutes 13 seconds)

Alan Green CEO of Brand Communications talks about: Cadence #KDNC Crawshaw Group #CRAW Acacia Mining #ACA (Interview starts at 38 minutes 7 seconds)

Plus the Top 5 Most Followed Companies on Vox Markets in the last 24 hours & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours. (Feature starts at 48 minutes 28 seconds)

Vox Markets is a stock market resource platform, that aggregates investor relations information.

It specialises in the latest stock market news, company information, live prices, interviews and views from Asset Managers, Stock Brokers, Hedge Fund Managers, Private Investors, Independent Financial Advisors and Investment Managers.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast